COST-EFFECTIVENESS OF GEMCITABINE (GEMZAR(TM)) PLUS CISPLATIN VERSUS ETOPOSIDE PLUS CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) IN SPAIN

Authors
ROSELL R SACRISTAN JA DUTHIE T CARDENAL F ARTAL A CARRATO A LOMAS M BARNETO I BAMETO I MASSUTI B
Citation
R. Rosell et al., COST-EFFECTIVENESS OF GEMCITABINE (GEMZAR(TM)) PLUS CISPLATIN VERSUS ETOPOSIDE PLUS CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) IN SPAIN, Annals of oncology, 9, 1998, pp. 445-445
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
445 - 445
Database
ISI
SICI code
0923-7534(1998)9:<445:COG(PC>2.0.ZU;2-F